Format

Send to

Choose Destination
See comment in PubMed Commons below
J Appl Physiol (1985). 2014 Sep 15;117(6):577-85. doi: 10.1152/japplphysiol.00326.2014. Epub 2014 Jul 18.

Measuring diffusion limitation with a perfusion-limited gas--hyperpolarized 129Xe gas-transfer spectroscopy in patients with idiopathic pulmonary fibrosis.

Author information

1
Department of Biomedical Engineering, Duke University, Durham, North Carolina; Center for In Vivo Microscopy, Duke University Medical Center, Durham, North Carolina; ssk13@duke.edu.
2
Center for In Vivo Microscopy, Duke University Medical Center, Durham, North Carolina; Medical Physics Graduate Program, Duke University, Durham, North Carolina;
3
Medical Physics Graduate Program, Duke University, Durham, North Carolina;
4
University College London, London, United Kingdom;
5
Department of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina; and.
6
Department of Radiology, Duke University Medical Center, Durham, North Carolina.
7
Department of Biomedical Engineering, Duke University, Durham, North Carolina; Center for In Vivo Microscopy, Duke University Medical Center, Durham, North Carolina; Medical Physics Graduate Program, Duke University, Durham, North Carolina; Department of Radiology, Duke University Medical Center, Durham, North Carolina.

Abstract

Although xenon is classically taught to be a "perfusion-limited" gas, (129)Xe in its hyperpolarized (HP) form, when detected by magnetic resonance (MR), can probe diffusion limitation. Inhaled HP (129)Xe diffuses across the pulmonary blood-gas barrier, and, depending on its tissue environment, shifts its resonant frequency relative to the gas-phase reference (0 ppm) by 198 ppm in tissue/plasma barrier and 217 ppm in red blood cells (RBCs). In this work, we hypothesized that in patients with idiopathic pulmonary fibrosis (IPF), the ratio of (129)Xe spectroscopic signal in the RBCs vs. barrier would diminish as diffusion-limitation delayed replenishment of (129)Xe magnetization in RBCs. To test this hypothesis, (129)Xe spectra were acquired in 6 IPF subjects as well as 11 healthy volunteers to establish a normal range. The RBC:barrier ratio was 0.55 ± 0.13 in healthy volunteers but was 3.3-fold lower in IPF subjects (0.16 ± 0.03, P = 0.0002). This was caused by a 52% reduction in the RBC signal (P = 0.02) and a 58% increase in the barrier signal (P = 0.01). Furthermore, the RBC:barrier ratio strongly correlated with lung diffusing capacity for carbon monoxide (DLCO) (r = 0.89, P < 0.0001). It exhibited a moderate interscan variability (8.25%), and in healthy volunteers it decreased with greater lung inflation (r = -0.78, P = 0.005). This spectroscopic technique provides a noninvasive, global probe of diffusion limitation and gas-transfer impairment and forms the basis for developing 3D MR imaging of gas exchange.

KEYWORDS:

diffusion limitation; gas-transfer spectroscopy; hyperpolarized 129Xe; idiopathic pulmonary fibrosis

PMID:
25038105
PMCID:
PMC4157168
DOI:
10.1152/japplphysiol.00326.2014
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center